 | Up a level |
Journal Article
Brandt, Maximilian Peter, Ruf, C., Dieckmann, K. P., Syring, I, Ruckes, C., Nestler, T., Schmelz, H. U., Dotzauer, R., Hiester, A., Albers, P., Nettersheim, D., Bolenz, C., Loosen, S. H., Heidenreich, A., Pfister, D., Haferkamp, A., Zengerling, F. and Paffenholz, P. (2022). Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer. World J. Urol., 40 (2). S. 327 - 335. NEW YORK: SPRINGER. ISSN 1433-8726
Heidenreich, A., Paffenholz, P., Nestler, T. and Pfister, D. (2022). Nerve sparing retroperitoneal lymph node dissection for clinical stage IIA/B seminomas: A clinical phase II trial. Ann. Oncol., 33 (7). S. S777 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Nestler, T., Borgmann, H. and Salem, J. (2016). GeSRU-StepS! - urologic surgery teaching videos at the annual meeting of the German Society for Urology. Urologe, 55 (9). S. 1244 - 1246. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563
Nestler, T., Salem, J., Struck, J. P. and Ralla, B. (2017). Support of the urological Offspring The GeSRU-Supporting Membership Offenbach. Urologe, 56 (11). S. 1473 - 1475. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563
Paffenholz, P., Angerer-Shpilenya, M., Kauffmann, C., Grabbert, M., Nestler, T., Petermann-Meyer, A., Pfister, D. and Heidenreich, A. (2018). Distress screening in patients with urogenital malignancies. Oncol. Res. Treat., 41. S. 77 - 79. BASEL: KARGER. ISSN 2296-5262
Paffenholz, P., Nestler, T., Kauffmann, C., Grabbert, M., Pfister, D. and Heidenreich, A. (2018). Non-guideline concordant treatment of testicular cancer is associated with a reduced relapse-free survival. Oncol. Res. Treat., 41. S. 77 - 78. BASEL: KARGER. ISSN 2296-5262
Paffenholz, P., Nestler, T., Maatoug, Y., von Brandenstein, M., Loosen, S., Fischer, N., Pfister, D. and Heidenreich, A. (2020). Teratomatous elements in orchiectomy specimens are associated with a reduced relapse-free survival in metastasized testicular germ cell tumors. Oncol. Res. Treat., 43 (SUPPL 4). S. 126 - 127. BASEL: KARGER. ISSN 2296-5262
Paffenholz, P., Nestler, T., Pfister, D. and Heidenreich, A. (2020). Using pre-orchiectomy tumor marker levels for International Germ Cell Consensus Classification (IGCCCG) risk group assignment results in significant numbers of up- and downstaging. Oncol. Res. Treat., 43 (SUPPL 4). S. 127 - 128. BASEL: KARGER. ISSN 2296-5262
Paffenholz, P., Nestler, T., Seelemeyer, F., von Brandenstein, M., Koeditz, B., Pfister, D. and Heidenreich, A. (2022). Early relapse in seminoma is associated with reduced overall survival. Ann. Oncol., 33 (7). S. S778 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Paffenholz, P., Salem, J., Syring, I., Zengerling, F., Brandt, M. P., Hermann, J., Nestler, T., Schubert, M., Ernst, S., Ruf, C. and Schlenker, B. (2017). GeSRU Testicular Cancer App Staging from the Pocket. Urologe, 56 (8). S. 1044 - 1047. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563
Ralla, B., Arnold, H., Konig, J., Cebulla, A., Nestler, T., Struck, J., Borgmann, H. and Salem, J. (2017). Relaunch of the GeSRU Website Strategy, Concept and Implementation. Urologe, 56 (4). S. 512 - 515. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563
Wundrack, F. -M., Paffenholz, P., Probst, K., Sanatgar, N., Cebulla, A., Nestler, T., Struck, J., Nachite-Berges, S., Salem, J. and Ralla, B. (2017). GeSRU programs at regional urology meetings in Germany 2017. Urologe, 56 (6). S. 804 - 806. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563